85
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Metabolic changes of different high-resolution computed tomography phenotypes of COPD after budesonide–formoterol treatment

, , , , , , & show all
Pages 3511-3521 | Published online: 06 Dec 2017

References

  • MirrakhimovAEChronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphonyCardiovasc Diabetol20121113223101436
  • AgustiASinDDBiomarkers in COPDClin Chest Med201435113114124507841
  • SunXWGuSYLiQYPulmonary function parameters in high-resolution computed tomography phenotypes of chronic obstructive pulmonary diseaseAm J Med Sci2015349322823325607515
  • MiravitllesMCalleMSoler-CataluñaJJClinical phenotypes of COPD: identification, definition and implications for guidelinesArch Bronconeumol2012483869822196477
  • NicholsonJKLindonJCSystems biology: metabonomicsNature200845572161054105618948945
  • AdamkoDJNairPMayersIMetabolomic profiling of asthma and chronic obstructive pulmonary disease: a pilot study differentiating diseasesJ Allergy Clin Immunol2015136357158026152317
  • VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 reportAm J Respir Crit Care Med2017195555728128970
  • TrudoFKernDMDavisJRComparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatmentsInt J Chron Obstruct Pulmon Dis2015102055206626451101
  • GoddardPRNicholsonEMLaszloGWattIComputed tomography in pulmonary emphysemaClin Radiol19823343793877083738
  • DejaSPorebskaIKowalAMetabolomics provide new insights on lung cancer staging and discrimination from chronic obstructive pulmonary diseaseJ Pharm Biomed Anal201410036938025213261
  • SinDDJohnsonMGanWQManSFCombination therapy of inhaled corticosteroids and long-acting beta2-adrenergics in management of patients with chronic obstructive pulmonary diseaseCurr Pharm Des200410283547356015579052
  • MottaAParisDD’AmatoMNMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperaturesJ Proteome Res201413126107612025393672
  • AiroldiCCiaramelliCFumagalliM1H NMR to explore the metabolome of exhaled breath condensate in α1-antitrypsin deficient patients: a pilot studyJ Proteome Res201615124569457827646345
  • WangLTangYLiuSMetabonomic profiling of serum and urine by 1H NMR-based spectroscopy discriminates patients with chronic obstructive pulmonary disease and healthy individualsPLoS One201386e6567523755267
  • NazSKolmertJYangMMetabolomics analysis identifies sex-associated metabotypes of oxidative stress and the autotaxin-lysoPA axis in COPDEur Respir J2017496160232228642310
  • JagoeRTEngelenMPMuscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary diseaseEur Respir J Suppl200346552s63s14621107
  • CrulTTestelmansDSpruitMAGene expression profiling in vastus lateralis muscle during an acute exacerbation of COPDCell Physiol Biochem201025549150020332630
  • NaimiAIBourbeauJPerraultHAltered mitochondrial regulation in quadriceps muscles of patients with COPDClin Physiol Funct Imaging201131212413121091605
  • PouwEMLangKDGoskerHRMuscle metabolic status in patients with severe COPD with and without long-term prednisoloneEur Respir J200016224725210968499
  • NobakhtMGhBFAliannejadRRezaei-TaviraniMTaheriSOskouieAAThe metabolomics of airway diseases, including COPD, asthma and cystic fibrosisBiomarkers201520151625403491
  • LaymanDKWalkerDABranched-chain amino acids: metabolism, physiological function, and applicationJ Nutrition20061361319S323S16365106
  • SnowdenSDahlénSEWheelockCEApplication of metabolomics approaches to the study of respiratory diseasesBioanalysis20124182265229023046268
  • UbhiBKRileyJHShawPAMetabolic profiling detects bio-markers of protein degradation in COPD patientsEur Respir J201240234535522183483
  • RochaCMCarrolaJBarrosASMetabolic signatures of lung cancer in biofluids: NMR-based metabonomics of blood plasmaJ Proteome Res20111094314432421744875
  • DeLGParisDMelckDMetabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopyEur Respir J20083251175118318653649
  • SethiSMahlerDAMarcusPOwenCAYawnBRennardSInflammation in COPD: implications for managementAm J Med2012125121162117023164484
  • NakanoYWongJCde JongPAThe prediction of small airway dimensions using computed tomographyAm J Respir Crit Care Med2005171214214615516531
  • PerezTMalHAguilaniuBCOPD and inflammation: statement from a French expert group. Phenotypes related to inflammationRev Mal Respir201128219221521402234
  • Effenberger-NeidnichtKJägersJVerhaeghRde GrootHGlycine selectively reduces intestinal injury during endotoxemiaJ Surg Res2014192259259825012270
  • JainMNilssonRSharmaSMetabolite profiling identifies a key role for glycine in rapid cancer cell proliferationScience201233660841040104422628656
  • DasUNPyruvate is an endogenous anti-inflammatory and anti-oxidant moleculeMed Sci Monit2006125RA79RA8416641887
  • HirschhaeuserFSattlerUGAMuellerklieserWLactate: a metabolic key player in cancerCancer Res20117122692122084445
  • MillsEO’NeillLAJSuccinate: a metabolic signal in inflammationTrends Cell Biol201424531332024361092
  • HolmesELooRLStamlerJHuman metabolic phenotype diversity and its association with diet and blood pressureNature2008453719339640018425110